378 related articles for article (PubMed ID: 25123481)
21. Live-cell single-particle tracking photoactivated localization microscopy of Cascade-mediated DNA surveillance.
Turkowyd B; Müller-Esparza H; Climenti V; Steube N; Endesfelder U; Randau L
Methods Enzymol; 2019; 616():133-171. PubMed ID: 30691641
[TBL] [Abstract][Full Text] [Related]
22. The structural biology of CRISPR-Cas systems.
Jiang F; Doudna JA
Curr Opin Struct Biol; 2015 Feb; 30():100-111. PubMed ID: 25723899
[TBL] [Abstract][Full Text] [Related]
23. Structural organization of a Type III-A CRISPR effector subcomplex determined by X-ray crystallography and cryo-EM.
Dorsey BW; Huang L; Mondragón A
Nucleic Acids Res; 2019 Apr; 47(7):3765-3783. PubMed ID: 30759237
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
Numata T; Inanaga H; Sato C; Osawa T
J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
[TBL] [Abstract][Full Text] [Related]
25. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
[TBL] [Abstract][Full Text] [Related]
26. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
Xiao Y; Ng S; Nam KH; Ke A
Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for assembly of non-canonical small subunits into type I-C Cascade.
O'Brien RE; Santos IC; Wrapp D; Bravo JPK; Schwartz EA; Brodbelt JS; Taylor DW
Nat Commun; 2020 Nov; 11(1):5931. PubMed ID: 33230133
[TBL] [Abstract][Full Text] [Related]
28. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
29. Structures of the CRISPR genome integration complex.
Wright AV; Liu JJ; Knott GJ; Doxzen KW; Nogales E; Doudna JA
Science; 2017 Sep; 357(6356):1113-1118. PubMed ID: 28729350
[TBL] [Abstract][Full Text] [Related]
30. Formation and Stoichiometry of CRISPR-Cascade Complexes with Varying Spacer Lengths Revealed by Native Mass Spectrometry.
Wittig S; Songailiene I; Schmidt C
J Am Soc Mass Spectrom; 2020 Mar; 31(3):538-546. PubMed ID: 32008319
[TBL] [Abstract][Full Text] [Related]
31. Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry.
Guo M; Zhang K; Zhu Y; Pintilie GD; Guan X; Li S; Schmid MF; Ma Z; Chiu W; Huang Z
Cell Res; 2019 Apr; 29(4):305-312. PubMed ID: 30814678
[TBL] [Abstract][Full Text] [Related]
32. Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.
You L; Ma J; Wang J; Artamonova D; Wang M; Liu L; Xiang H; Severinov K; Zhang X; Wang Y
Cell; 2019 Jan; 176(1-2):239-253.e16. PubMed ID: 30503210
[TBL] [Abstract][Full Text] [Related]
33. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
Majsec K; Bolt EL; Ivančić-Baće I
BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
[TBL] [Abstract][Full Text] [Related]
35. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
[TBL] [Abstract][Full Text] [Related]
36. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
Osawa T; Inanaga H; Numata T
J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
[TBL] [Abstract][Full Text] [Related]
38. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
[TBL] [Abstract][Full Text] [Related]
39. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
[TBL] [Abstract][Full Text] [Related]
40. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
